top of page
Lampe - White Typeface.png

Student Design Teams

Stampede Solutions

Alexa Shaffer

Domenico Norton

Declan Davis

Sarah-Courtney Cavatoni

StampedeSolutions - Sarah-Courtney Cavatoni.jpg

SynThrive

Srilekha Venkatraman

Sri Sruthi Potluru

Hattie Hensley

Alaina Parker

SynThrive Logo - Srilekha Venkatraman.png

Three Musketeers

Samanyu Dixit

Dhruv Ranganath

Chinmay Singh

ThreeMuskLogo - Samanyu Dixit.jpg

Big Fish Technologies

Sophia Ly

Elaina Berney

Emily Foley

Robert Dong

Jackson Lyman

Danica Grant

Big Fish Technologies Logo - Sophia Ly.jpg

AltivO MedTech

Joseph Stark

Elias Starogiannis

Ryan Voorhees

John Pawlowski

Aram Mirabedini

Altivo MedTech Logo - Joseph Stark.png

DWACK Engineering

David Barr

Will Brooks

Andrew Lane

Charlie Duchene

Kyle Newman

EngineeringDesign - Charlie Duchene.png

Sanguine Medical

William Lee

Akshar Patel

Sekar Dhanasekar

Raghav Sriram

Aman Prasanna

Sanguine Medical - William Lee.png

Manta MedTech

Ava Armstrong

Madison Norem

Avery Murray

Noah Cleaton

Taylor Stith

MantaMedTech - Ava Armstrong.png

BioWolf Engineering

Sam Hoy

JC Zino

Will Holbrook

Kevin Clarke

Caleb Harker

BioWolfEngineering - John Zino.png

S(U)PERB

Jessica Eng

Heather Rinehardt

Zaynah Karimi

Jessica Martinez

Brooke Hawkins

Fatimah Khalil

S(U)PERB Transparent Logo - Jessica Eng.png

TriceraTech

Matthew Ramsey

Nathan Glymph

Munish Nidadavolu

Lila Issa

Hannah Spainhour

Noah Solomon

Triceratech_Logo_Small - Matthew Ramsey.png

ITERA

Aidan McCloskey

Brendan Smith

Casey Chason

Connor Bryan-Haigler

Conor Merrin

Karl Shroff

ITERA - Karl Shroff.png

BioPack Innovations

Herry Wang

Ashley Dehn

Colby Mennen

Duncan Wilson

Makayla Hines

Matthew Malak

BioPack_Innovations - Herry Wang.jpg

B4Med

Brendan Lyons

Preethi Coulter

Bella Ruiz

Mylah Williams

Anna Castillo

B4Med - Anna Castillo.jpg

LumaVida

Anthony Huynh-king

Jehosh Jebaraj

Maria Jenkins

Ashley Kong

Preye Porbeni

Srigouri Rudravaram

LumaVida - Ashley Kong.jpg

Circuitcell Biotech

Ford Bryson

Carly Koop

Paige Gill

Hanlon Mayhue

Amy Preston

Duru Caner

Circuitcell Biotech - Duru Caner.jpeg

LifeLink Engineering

Jasmine Facchetti

Samantha Florack

Artemis Badger

Charlie Kale

Milana Nostrand

Lifelink Engineering - Milana Nostrand.jpg

Lupa

Joanna Cardenas

Audrey Clark

Anshika Gutta

Noor Horani

Anna Powell

Yamini Ramadurai

Lupa - Yamini Ramadurai.jpg

SELLR Medical

Steve Recchio

Ellie Citrano

Lily Loker

Luke Williams

Rahul Pradhan

Sellr Medical - Steve Recchio.png

MonoVida

Connor Moore

Ashley Reyes

Sophia Houck

Emily Beckman

Natalie Hunt

Jacob Casey

MonoVida_Logo - Connor Moore.png

TheraTech

Sarah Asher

Colby Chaney

Owen Frey

Matt Mello

Emily Rodger

Caroline Strickland

TheraTech - Matt Mello.jpg

A.D.A.P.T. Medical

Aditi Bharath

Alicia Norman

Emma Little

Jordan Saunders

ADAPT_Logo.jpg

TinyTubes

Amy Hume

Kino Deligero

Kubrick Hilton

Lana Maizel

Max Trbonja

Jana Khalafallah

TinyTubes_Logo.jpg

Nogi

Neev Gupta
Bryce Womble

Matthew Kok
William Sellers
Varun Varadarajan
Jake Rose

Nogi - Logo.png

MWH Industries

Meghan Parker

Sree Elayaperumal

Bright Crosswell

Andy Choe

Tyler Tan

Nikhil Sathyanathan

mwhlogo.png

Innogen

Xuren Ni
Braden Messersmith
Nishant Dengi
Grant Holland

Innogen Team Logo.png

MedWave

Kevin Cheng

Spencer Dougherty

Silas Edmonson

Noah Lambert

John Le

Perry Tseng

MedWave logo.jpg

Materalis

Eden Spofford

Nirandra Sivakumar

Ryan Joseph

Esther Lee

Kaymille Sherman

Gavin Wiltshire

Logo_Materalis.jpg

FelineVision

Nontsikelelo Dos Santos

William Seung

Tyler Nguyen

Muhammad Patel

Miguel Martinez Leal

Aoife Kelly

FelineVision Logo.jpeg

SigmaSix

Samantha Carew

Allison Pridmore

Carmen Sagues

Jayden Joseph

Sujay Patel

Nishanth Konduru

SigmaSix_Logo.jpg

The Heelin’ Pack

Beesan Shehadeh

Alicia Equan

Miguel Canamary Otoch

Vinusha Venkatesh

Stella Prophate

the heelin pack.png

Temporary Tapping Therapeutics

Stacy Andrews

Megan Brantly

Devon Cholon

Sway Fernandez

Kelly Kang

Lyssa Menendez

Temporary Tapping Therapeutics Logo.jpg

Stampede Solutions is a multidisciplinary team of student engineers and former athletes focused on reducing ACL injuries through accessible technology. Their project centers on KTrax, a wearable knee sleeve that dynamically estimates knee abduction angle during athletic activity. By enabling real-time, on-field monitoring, the team aims to address a major gap between expensive lab-based screening and practical injury prevention. The solution is designed to be affordable, portable, and non-invasive, supporting athletes, coaches, and clinicians in identifying high-risk movement patterns, improving performance, and helping prevent serious knee injuries before they occur.

SynThrive has developed a burn dressing to address wound monitoring and infections in patients under the age of 5 with second-degree burns. The dressing contains hydrogel-based materials to hydrate and cool the wound, reducing pain when the dressing is removed. The dressing utilizes a color-changing mechanism, in which it changes color when there is a pH change, indicating presence of infection in the wound site and alerting physicians once this occurs. The dressing also incorporates low-grade antibiotics that are safe for pediatric patients to prevent and initially treat wound-site infections.

Three Musketeers is developing an immersive virtual rehabilitation system for stroke survivors who experience a loss of fine motor control. By pairing a VR environment with a haptic glove, the system provides essential tactile feedback that bridges the gap between virtual intent and physical sensation. This sensory reinforcement is critical for triggering neuroplasticity, allowing the brain to effectively relearn the precise movements required for self-feeding, a key indicator of independence. Unlike expensive clinical alternatives, this affordable, at-home solution increases patient adherence and restores functional independence for the essential activities of daily living.

Big Fish Technologies is developing the Angler, an innovative hip brace with an integrated goniometer designed to support recovery after major hip surgeries such as hip replacement. The Angler tracks patient movement and monitors compliance with prescribed motion limits, helping ensure safe rehabilitation. By measuring hip angles in real time, the device alerts patients when movements may be harmful or slow recovery. This feedback helps patients stay within safe ranges while giving clinicians useful recovery data. The Angler aims to improve healing outcomes, reduce complications, and increase patient confidence by providing clear guidance during the rehabilitation process.

Altivo MedTech is developing a continuous inflammation monitoring device for patients with chronic inflammatory diseases such as lupus and gout. This allows the patient to identify an incoming flare-up and be able to treat it quicker. This novel solution will lead to quicker and safer treatment for inflammatory conditions, making the patient's quality of life better.

DWACK Engineering is developing an at-home solution for treating chemotherapy-induced peripheral neuropathy (CIPN). The solution provides electrical stimulation to the lower extremities to reduce pain and numbness associated with CIPN. Electrical stimulation is backed by multiple scientific studies involving CIPN pain management. This novel solution will lead to a greater quality of life in those suffering from CIPN.

Sanguine Medical is developing SanguineSense, a minimally invasive gastrointestinal sampling probe designed to improve assessment of suspected upper GI bleeding, particularly in intermediate-risk patients where clinical decisions are often uncertain. Current evaluation methods can be slow or inconclusive, leading to extended observation or unnecessary procedures. The device features a small, flexible shaft with segmented absorbent regions that passively collect gastric contents during brief insertion. After removal, clinicians visually inspect the segments for evidence of blood, providing a simple, rapid, and low-complexity method to support clinical decision-making without reliance on advanced instrumentation.

Manta MedTech is developing a dynamic pressure-relief device for patients undergoing prolonged prone spinal and orthopedic surgeries. During these procedures, prolonged facial pressure from static pillows or headrests can cause tissue injury and reduced perfusion, particularly at facial bony prominences. The device supports safe and consistent positioning for patients in the prone position during extended procedures. By incorporating controlled pneumatic pressure modulation, it redistributes facial load to reduce localized pressure buildup. This novel approach aims to minimize intraoperative pressure injuries, improve patient safety, and enhance postoperative recovery outcomes.

BioWolf Engineering is developing a tissue detecting needle for facial injections which allows the user to quickly and accurately determine where exactly the tip of the needle is inside the patient. This solution will lead to drastic decreases in embolisms and dangerous facial injections that can cause harm to the patient.

The DosEYE dropper, developed by S(U)PERB, is a reusable eye-drop assistance device designed to help geriatric patients administer eye medication safely and independently. This product assists geriatric patients in the self-administration of ophthalmic medications by improving the accuracy of drop placement and reducing the physical effort required to dispense eye drops.

TriceraTech is developing a new thermal ablation catheter with improved flexibility that will allow clinicians to consistently treat varicose veins of greater tortuosity than current ablation catheters can treat. This novel solution will lead to greater success in treating ablated veins and preventing reoccurrence.

ITERA is developing VenaKnight, a non-invasive screening and risk‑scoring system for deep vein thrombosis. The system integrates a suite of biosensors to continuously detect developing embolus risk in immobilized patients. By translating physiologic signals into an intuitive thrombosis risk score at the bedside, VenaKnight enables clinicians and high‑risk, bed‑bound patients to act earlier, reducing the likelihood and severity of otherwise silent embolic events and related consequences.

BioPack Innovations is developing a 22-Gauge Biopsy Needle Sleeve for use in EUS Biopsy operations to prevent damage to the endoscope channel caused by bent needles due to excessive force during the operation. This device will help guide and wrap around the bent needle to prevent it from dragging against the endoscope channel to reduce damage to the channel, which will eliminate grooves and cuts in the channel that would require repair or replacement of the channel, saving time and money for hospital equipment.

HORTH is a developing modified bone reduction forceps designed for large animal surgical procedures. The surgical device addresses the need for precise manual bone reduction and stabilization, often required by orthopedic surgeons. This reusable, invasive device transmits controlled mechanical force through its handles to specialized jaws to facilitate the temporary grasping, fixation, and alignment of bone or implant fragments. By enabling accurate anatomical reduction during surgical procedures, HORTH leads to improved outcomes and happier patients.

LumaVida is developing a better sealing method for bag valve masks, which ensures that clinicians can reduce the number of hands needed for a bag valve mask resuscitation while also providing a better mask seal. This novel solution will lead to more freedom for clinicians to maneuver as needed, as well as reduce the amount of oxygen escaping the mask due to improper seal.

FindNine is a device that makes use of electrochemical sensors to test for the presence and quantity of active MMP-9 enzymes in the blood. This device is meant to be used to test wounds for early signs of infection via classifying the inflammation seen at the site. This solution will yield faster results than current methods on the market, allowing patients to be treated in a more efficient manner.

Current prosthetic alignment devices enable transfer of alignment from a test socket to a final prosthesis, but they are often bulky and limit how many clinicians can use them at once. Lifelink Engineering will develop an automated alignment transfer system designed to increase accessibility and streamline processes in clinical settings. By enabling multiple clinicians to use the device simultaneously, the system aims to improve workflow efficiency while maintaining consistent alignment between test and final prostheses.

Lupa is developing a pediatric vitals monitoring device, in the form of a bassinet, titled “The Waybie”. This device can be used in both traditional settings, like pediatric offices, and non-traditional settings, such as rural or smaller hospitals with no neonatal sections, home births with midwives, etc. This novel solution will provide ease to physicians ergonomically for recording measurements, with increased accuracy. The Waybie is intended for use on newborns ages 0-3 months and will record weight, heart rate, and blood oxygen saturation.

Our project is developing a non-invasive magnetic guidance system to improve the accuracy of neonatal catheter placement. Current methods rely heavily on clinician experience and imaging, which can lead to misplacement and complications. This solution uses an array of external magnetic sensors to track the position of a small magnet embedded at the catheter tip in real time. Designed for neonatal patients, the system aims to reduce procedural errors, minimize the need for repeated insertions, and improve patient outcomes by enabling safer, faster, and more precise catheter navigation.

MonoVida is developing a rapid urine screening catch-cup designed to improve detection of urinary tract infections, one of the most common bacterial infections affecting patients in home and clinical settings. Current diagnosis typically requires sending urine samples to a laboratory for bacterial culture, delaying treatment and increasing healthcare burden. Our device integrates a lateral flow assay for bacterial detection with a multi-parameter test strip that measures additional UTI indicators. This easy-to-use, single-use solution aims to deliver clear results within minutes, enabling faster screening, supporting timely treatment decisions, and improving access to convenient urinary health testing.

Developing an intraoperative angle guidance system for orthopedic bone-cutting procedures such as Weil osteotomies, where surgeons currently rely on visual estimation and static guides that do not provide real-time feedback. This can lead to inconsistent cut angles and suboptimal postoperative outcomes for patients with forefoot deformities. The device delivers continuous, real-time angle information directly at the point of use in a sterile-compatible form factor. The goal is to improve surgical accuracy, reduce variability between surgeons, and enhance alignment outcomes without adding complexity to existing surgical workflows.

The A.D.A.P.T. system focuses is a smart, adaptive uterine tamponade device for the treatment of postpartum hemorrhage (PPH). The device uses a deployable loop structure to conform to varying uterine anatomies and a vacuum-assisted mechanism to evacuate blood and promote uterine contraction. An integrated cervical seal is designed to minimize leakage and maintain effective suction. The system aims to improve reliability, reduce failure rates associated with current tamponade devices, and enable rapid, user-friendly deployment.

Our device is designed to continue mixing blood before, during, and after transportation through a hospital pneumatic tube system. The device is intended to be used with samples from patients within the neonatal intensive care unit. It differs from blood rockers on the market due to its ability to continue mixing blood within the pneumatic tube canister. This prevents the blood from remaining stagnant for long periods of time in the event of a pneumatic tube system jam or testing backlog. This should lower the concerningly high incidence of blood sample coagulation and subsequent sample rejection in this population.

Nogi is developing a device that will measure temperature and pressure within existing diabetic footwear solutions. This novel approach will allow clinicians to understand the effectiveness of their treatment and predict ulcer formation.

Our mission is to make pulse checks during cardiac arrest faster, more accurate, and less dependent on human interpretation by replacing manual palpation with a dual-sided, light-based pulse detection device. By reducing the duration and complexity of pulse checks, healthcare teams can maintain focus on high-quality chest compressions and other critical interventions with minimal interruption. With this device, we aim to improve survival and neurological outcomes, especially in resource-constrained environments with limited personnel. 

Innogen is developing a pressure-sensing device for the fingertips used
during TMD-related palpation examinations. The device enables clinicians
to obtain objective pressure measurements at the point when muscle pain
is elicited during facial palpation. By quantifying the pressure applied during
these examinations, the technology provides a standardized method for
evaluating the accuracy of diagnoses and the effectiveness of treatment
procedures.

MedWave is developing a device that relieves overnight foot pain in patients with diabetic peripheral neuropathy. This novel solution will utilize stochastic resonance vibrational therapy to stimulate C-fibers in the ankle and decrease the perception of pain for patients, thus improving sleep metrics and overall quality of life, as well as ensuring normal nerve function during periods of sleep.

The Materalis team is developing a point-of-care device that postpartum mothers can use to determine if they are at risk for developing a life threatening blood clot, called an embolism, in the six to eight weeks following childbirth. This novel solution plans to reduce the number of postpartum patients who are prophylactically prescribed anticoagulant medication while also reducing the number of patients who develop an embolism.

Our team is developing a wearable navigation device to assist individuals with Retinitis Pigmentosa, a progressive retinal condition that causes peripheral vision loss and difficulty detecting obstacles in surrounding environments. People with this condition often face challenges navigating crowded or unfamiliar spaces, which can reduce independence and increase the risk of collisions or falls. The device uses environmental sensors and haptic feedback to provide real-time alerts about nearby obstacles and changes in surroundings. This approach aims to improve self reported scores in spatial awareness and confidence, ultimately supporting safer navigation and greater independence in daily mobility.

SigmaSix is developing the SigmaSix Intelligent Tourniquet (SSIT), an innovative medical device designed to provide objective feedback during life-threatening limb hemorrhage. Current tourniquets often fail due to subjective application, leading to either continued bleeding or permanent nerve damage from excessive pressure. The SSIT addresses these risks by integrating a finger/toe pulse sensor that provides a real-time visual alert once arterial occlusion is achieved. Featuring a locking ratcheting mechanism on the band for precise tensioning and an integrated ischemia timer to track time since application, the SSIT replaces clinical guesswork with data-driven feedback. Our goal is to standardize effective occlusion, improve survival rates, and minimize long-term complications for patients in emergency and tactical environments.

We are developing a wearable cooling glove designed to reduce the incidence and severity of chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer patients receiving neurotoxic treatments such as taxane or platinum-based chemotherapy. The device delivers controlled, localized cooling to the fingers using circulating chilled water, with continuous monitoring of water temperature to ensure safe and consistent delivery. By improving temperature regulation compared to traditional ice-based methods, this solution aims to protect nerve function without compromising comfort or usability. The intended outcome is reduced neuropathy symptoms, preserved sensory function, and improved quality of life during and after chemotherapy treatment.

Temporary Tapping Therapeutics is developing a bioabsorbable orthopedic fixation material intended for pediatric avulsion fractures. The project focuses on creating a polylactic acid (PLA) and nano-hydroxyapatite (nHA) composite designed to provide sufficient fracture-site compression while gradually resorbing in the body, eliminating the need for a secondary implant removal surgery. The material is fabricated and evaluated through mechanical testing (strength, stiffness, and failure behavior) and in vitro cytotoxicity assessment to verify biocompatibility. The long-term goal is to translate the material into a resorbable screw that supports bone healing while reducing surgical burden and recovery risk for adolescent patients.

54493005374_6b80aed50e_6k.jpg
Artboard 2_8.png

© 2022 by Joint Dept of BME.

bottom of page